Ningxia Zhongke Biotechnology Co., Ltd.
Shanghai Stock Exchange 600165.SS
Ningxia Zhongke Biotechnology Co., Ltd. Gross Profit Margin for the year ending December 31, 2023: -47.12%
Ningxia Zhongke Biotechnology Co., Ltd. Gross Profit Margin is -47.12% for the year ending December 31, 2023, a -524.02% change year over year. Gross Profit Ratio is the ratio of gross profit to net sales, indicating the percentage of revenue that exceeds the cost of goods sold and reflects the efficiency of a company in managing its production or procurement and sales.
-
Ningxia Zhongke Biotechnology Co., Ltd. Gross Profit Margin for the year ending December 31, 2022 was 11.11%, a -10.53% change year over year.
-
Ningxia Zhongke Biotechnology Co., Ltd. Gross Profit Margin for the year ending December 31, 2021 was 12.42%, a -4.07% change year over year.
-
Ningxia Zhongke Biotechnology Co., Ltd. Gross Profit Margin for the year ending December 31, 2020 was 12.95%, a 1,101.57% change year over year.
-
Ningxia Zhongke Biotechnology Co., Ltd. Gross Profit Margin for the year ending December 31, 2019 was 1.08%, a -87.25% change year over year.
Key data
| Date | Gross Profit Margin | Operating Income Margin | EBT Margin | Net Income Margin |
|---|
Market news
Loading...
Shanghai Stock Exchange: 600165.SS
| CEO | Mr. Rui Chen |
| IPO Date | May 29, 1998 |
| Location | China |
| Headquarters | Hengtai Business Building |
| Employees | 731 |
| Sector | Materials |
| Industries | |
Description
Ningxia Zhongke Biotechnology Co., Ltd. engages in the manufacturing chemical raw materials and chemical products. It offers coal-based activated carbon and lauric acid products, as well as manufactures bio-based chemical fibers. The company was founded in 1958 and is based in Yinchuan, China.
Key trends
Past 5 years
StockViz Staff
January 15, 2025
Any question? Send us an email